戻る Agenda
[S42] Think About Informed Consent from a Patient’s Perspective – What Can We Do to Promote Proper Understanding of Clinical Trials and PatientFriendly Clinical Trials?
Session Chair(s)
Kazuo Hasegawa
Representative Director
OnestepLung Cancer Patient Network ONE STEP, Japan
Informed consent is the first important process for patients to learn about and understand clinical trials. Recently, volume and complexity of Informed consent documents are increasing. In this session, we will discuss how we can improve informed consent documents and communication from a patient’s perspective based on the recent efforts in Japan and global.
Speaker(s)
Bringing Patient Centricity to Informed Consent and Promoting Understanding of Clinical Research Participation
David P. Leventhal, MBA
Pfizer Inc, United States
Enterprise Clinical Trial Data Sharing Lead, Global Data Dissemination
How Do We Make “Easy-to-Understand ICF” Come True?
Yumiko Miyazaki, MSc
Eli Lilly Japan K.K., Japan
Manager, Clinical Innovations & Business Integration,
From the Standpoint of CRC That Uses Various ICFs and Supports Many Subjects
Yukari Suzuki, RN
Nigata University Medical and Dental Hospital, Japan
Chief Clinical Research Coordinator, Clinical and Translational Research Center
Shinsuke Amano
Shinsuke Amano
Group Nexus Japan, Japan
Director